{"id":"W56664303","doi":"10.1097/01.sla.0000149427.84712.d9","title":"Treatment of Lung Cancer Using Clinically Relevant Oral Doses of the Cyclooxygenase-2 Inhibitor Rofecoxib","year":2005,"lang":"en","type":"article","venue":"Annals of Surgery","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; Merck Canada","keywords":"Rofecoxib; Medicine; Tumor Debulking; Cyclooxygenase; Lung cancer; Chemotherapy; Pharmacology; Internal medicine; Oncology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002676971,0.0003996443,0.0004996308,0.0001948248,0.0001470218,0.0003597766,0.000274826,0.0003945139,0.002019248],"category_scores_gemma":[0.0001341041,0.0000848994,0.0002315972,0.0001298222,0.0002784844,0.0002867841,0.0001051334,0.000858408,0.0004412603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002895664,"about_ca_system_score_gemma":0.0003543005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004442322,"about_ca_topic_score_gemma":0.001213314,"domain_scores_codex":[0.9998627,0.00002999238,0.00001123213,0.00002219836,0.00003896527,0.00003491569],"domain_scores_gemma":[0.9999043,0.00002253431,0.00002859058,0.000009166657,0.00001093466,0.00002438342],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.001203586,0.001925805,0.0007583005,0.0002585141,0.00003395724,0.00007672186,0.00002229546,0.0002491472,0.978001,0.0001093914,0.0002821338,0.01707918],"study_design_scores_gemma":[0.0008173818,0.04884894,0.01065071,0.00004774582,0.0001354496,0.0006671154,0.00005575646,0.0008993145,0.9305059,0.00005902911,0.007298976,0.00001373319],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843181,0.01106876,0.001542588,0.0003057972,0.00008832858,0.0001900569,0.0002976609,0.00007040126,0.00211822],"genre_scores_gemma":[0.9911472,0.004722578,0.001737224,0.00009405799,0.00007146553,0.0001074186,0.0004589018,0.000007370255,0.001653842],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002019248,"threshold_uncertainty_score":0.006755114,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1807599384729389,"score_gpt":0.4065440683657158,"score_spread":0.2257841298927769,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}